https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
In conclusion, our study suggested that the MCM complex might be a potential target and prognostic marker for OC patients. The choice of surgical method for clinically diagnosed T2 or higher stage kidney cancer remains controversial. Here, we systematically reviewed and collected published comparative studies on renal function, oncologic outcomes, and perioperative results of partial nephrectomy (PN) versus radical nephrectomy (RN) for larger renal tumors (T2 and above), and performed a meta-analysis. Following searches of
Curtir
Comentario
Compartilhar
